Short answer

Consumer insulin resistance scores can be useful as a risk conversation starter, but they are not the standard way prediabetes is diagnosed. The score may bundle fasting insulin, fasting glucose, lipoprotein patterns, or triglycerides into a single number, but routine diagnosis still leans on A1C, fasting plasma glucose, or an oral glucose tolerance test.

What the scores measure

Score or testWhat it usesMain caution
HOMA-IRFasting glucose and fasting insulin.Cutoffs vary, and it is often more research-oriented than diagnostic.
LP-IRLipoprotein particle sizes and numbers from advanced lipid testing.It is a risk marker, not a diabetes diagnosis.
A1C, fasting glucose, OGTTBlood glucose patterns.These are the standard tests used to diagnose prediabetes and diabetes.

What changes diagnosis

The standard prediabetes question is still whether blood glucose is in the A1C, fasting glucose, or OGTT range used by clinical guidelines. A score can add context, especially for metabolic syndrome, triglycerides, PCOS, or family history, but it should not replace the tests that actually set the diagnosis threshold.

What makes the result actionable

The best use of an insulin-resistance score is to support a practical plan: weight, waist circumference, blood pressure, triglycerides, HDL, A1C, fasting glucose, sleep, medicines, PCOS history, family history, and lifestyle changes. A score should not distract from proven diabetes-prevention steps or from diagnosing prediabetes with standard tests.

Questions to ask

  • What exact formula or lab method produced this score?
  • Was fasting insulin measured, or was the score inferred from lipoprotein particles?
  • How do my A1C, fasting glucose, triglycerides, HDL, waist, and blood pressure compare?
  • Would the plan change if I did not have this score?
  • Is this score meant to screen, monitor, or simply describe a metabolic pattern?

Related guides: fasting insulin test, A1C test, lipid panel, CGM for non-diabetics, and consumer metabolic age score claims.

Bottom line: insulin resistance scores can add context, but A1C, fasting glucose, OGTT, and cardiometabolic risk factors still carry most of the clinical decision weight.

FAQ

What is HOMA-IR?

HOMA-IR is a calculation based on fasting glucose and fasting insulin. It is widely used in research and sometimes in commercial reports, but cutoffs are not universal.

What is LP-IR?

LP-IR is a lipoprotein-based score that uses particle size and number patterns. It can signal metabolic risk, but it does not diagnose prediabetes or diabetes.

Can an insulin resistance score diagnose prediabetes?

No. Current clinical diagnosis still relies on A1C, fasting plasma glucose, or a 2-hour oral glucose tolerance test.

Why do scores and glucose tests not always match?

Some scores reflect insulin signaling or lipoprotein patterns before glucose rises, so they may disagree with A1C or fasting glucose in early or mixed cases.

What should I do if the score is high but my A1C is normal?

Use the score as a prompt to review weight, waist, lipids, blood pressure, sleep, family history, and whether a clinician thinks a formal glucose test is needed.

Are the cutoffs the same on every report?

No. Commercial thresholds vary by lab, method, and population, which is one reason these scores need careful interpretation.